Back

Association between initiation of sacubitril/valsartan and improved left ventricular ejection fraction in the real world

29 June 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Chronic Heart Failure - Treatment 1 Pharmacotherapy HFA Premium Access Heart Failure 2021

About the speaker

Photo
Professor Lars Lund

Karolinska University Hospital, Stockholm (Sweden)

7 More presentations in this session

Presentation thumbnail
Short-term changes in left and right ventricular CMR feature tracking strain following ferric carboxymaltose in patients with heart failure: a substudy of the Myocardial-IRON trial
Mr J. Nunez Villota (Valencia, ES)
Abstract Slides Video
Presentation thumbnail
Use of a portable elastomeric diuretic infusion pump to treat acute decompensated heart failure in an outpatient specialist nurse delivered multidisciplinary unit
Doctor S. Brousas (Liverpool, GB)
Abstract Slides Video
Presentation thumbnail
Acute QRS narrowing following CRT implantation is associated with improved survival
Mr D. Lapidot (Jerusalem, IL)
Abstract Slides Video
Presentation thumbnail
CardioMEMS reduce disease specific and all-cause hospitalizations, and lower mortality among patients with heart failure - A systematic review and meta analysis of incidence rates.
Doctor D. Verghese (Chicago, US)
Abstract Slides Video
Presentation thumbnail
Validation of a novel framework defining the acceptable standard of care for heart failure with reduced ejection fraction
Doctor P. Lopes (Carnaxide, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic Heart Failure - Treatment 1

The Event

Event poster

Heart Failure 2021

29 June - 1 July 2021
You may be interested in
thumbnail
Congress Presentation
Breaking the barriers in guideline-directed medical therapy implementation in heart failure - discussion
thumbnail
Congress Presentation
The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources